MedPath
FDA Approval

PRAVASTATIN SODIUM

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
January 4, 2021
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Pravastatin(40 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Denton Pharma, Inc. DBA Northwind Pharmaceuticals

Denton Pharma, Inc. DBA Northwind Pharmaceuticals

Denton Pharma, Inc. DBA Northwind Pharmaceuticals

080355546

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

PRAVASTATIN SODIUM

Product Details

NDC Product Code
70934-236
Application Number
ANDA207068
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 4, 2021
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MAGNESIUM OXIDEInactive
Code: 3A3U0GI71GClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3GClass: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBDClass: IACT
POVIDONEInactive
Code: FZ989GH94EClass: IACT
Code: 3M8608UQ61Class: ACTIBQuantity: 40 mg in 1 1
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
© Copyright 2025. All Rights Reserved by MedPath